133 related articles for article (PubMed ID: 31206033)
41. Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer.
Wang W; Zhang L; Wang Y; Ding Y; Chen T; Wang Y; Wang H; Li Y; Duan K; Chen S; Yang Q; Chen C
Cell Death Dis; 2017 Oct; 8(10):e3071. PubMed ID: 28981108
[TBL] [Abstract][Full Text] [Related]
42. MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting
Wu F; Li J; Guo N; Wang XH; Liao YQ
Am J Cancer Res; 2017; 7(3):405-416. PubMed ID: 28401000
[TBL] [Abstract][Full Text] [Related]
43. miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells.
Du G; Cao D; Meng L
Mol Med Rep; 2017 May; 15(5):2713-2719. PubMed ID: 28447761
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1.
Sun KX; Jiao JW; Chen S; Liu BL; Zhao Y
J Ovarian Res; 2015 Dec; 8():80. PubMed ID: 26626440
[TBL] [Abstract][Full Text] [Related]
45. MiR-18a upregulation enhances autophagy in triple negative cancer cells via inhibiting mTOR signaling pathway.
Fan YX; Dai YZ; Wang XL; Ren YQ; Han JJ; Zhang H
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2194-200. PubMed ID: 27338042
[TBL] [Abstract][Full Text] [Related]
46. Tissue inhibitor of metalloproteinase-1 protects MCF-7 breast cancer cells from paclitaxel-induced apoptosis by decreasing the stability of cyclin B1.
Wang T; Lv JH; Zhang XF; Li CJ; Han X; Sun YJ
Int J Cancer; 2010 Jan; 126(2):362-70. PubMed ID: 19609944
[TBL] [Abstract][Full Text] [Related]
47. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.
Wang G; Fang X; Han M; Wang X; Huang Q
Int J Mol Med; 2018 Mar; 41(3):1740-1748. PubMed ID: 29328362
[TBL] [Abstract][Full Text] [Related]
49. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.
Zhang C; Zhang Z; Zhang S; Wang W; Hu P
Med Sci Monit; 2017 Jan; 23():266-275. PubMed ID: 28090074
[TBL] [Abstract][Full Text] [Related]
50. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1.
Dong XL; Xu PF; Miao C; Fu ZY; Li QP; Tang PY; Wang T
Biomed Pharmacother; 2012 Feb; 66(1):70-5. PubMed ID: 22264882
[TBL] [Abstract][Full Text] [Related]
51. Quercetin suppresses the tumorigenesis of oral squamous cell carcinoma by regulating microRNA-22/WNT1/β-catenin axis.
Zhang C; Hao Y; Sun Y; Liu P
J Pharmacol Sci; 2019 Jun; 140(2):128-136. PubMed ID: 31257059
[TBL] [Abstract][Full Text] [Related]
52. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
[TBL] [Abstract][Full Text] [Related]
53. Resistance of breast cancer cells to paclitaxel is associated with low expressions of miRNA-186 and miRNA-7.
Apollonova V; Plevako D; Garanin A; Sidina E; Zabegina L; Knyazeva M; Smirnova V; Artemyeva A; Krivorotko P; Malek A
Cancer Drug Resist; 2023; 6(3):596-610. PubMed ID: 37842231
[No Abstract] [Full Text] [Related]
54. Clinical value of the expression levels of tumor protein D52 and miR-133a on prognosis assessment of pancreatic cancer surgery.
Wang ZY; Liu RH; Meng Y; Li JC
Pak J Med Sci; 2024; 40(4):723-729. PubMed ID: 38544991
[TBL] [Abstract][Full Text] [Related]
55. Determining KLF14 tertiary structure and diagnostic significance in brain cancer progression.
Zahra K; Shabbir M; Badshah Y; Trembley JH; Badar Z; Khan K; Afsar T; Almajwal A; Alruwaili NW; Razak S
Sci Rep; 2022 May; 12(1):8039. PubMed ID: 35577881
[TBL] [Abstract][Full Text] [Related]
56. Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?
Byrne JA; Frost S; Chen Y; Bright RK
Tumour Biol; 2014 Aug; 35(8):7369-82. PubMed ID: 24798974
[TBL] [Abstract][Full Text] [Related]
57. miR-139-5p Regulates Proliferation, Apoptosis, and Cell Cycle of Uterine Leiomyoma Cells by Targeting TPD52 [Expression of Concern].
Onco Targets Ther; 2020; 13():6855. PubMed ID: 32764976
[No Abstract] [Full Text] [Related]
58. Retracted: MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52.
Engineering JOH
J Healthc Eng; 2023; 2023():9829560. PubMed ID: 36741870
[TBL] [Abstract][Full Text] [Related]
59. Expression of miR-335 in triple-negative breast cancer and its effect on chemosensitivity.
Hao J; Lai M; Liu C
J BUON; 2019; 24(4):1526-1531. PubMed ID: 31646803
[TBL] [Abstract][Full Text] [Related]
60. Effects of MiR-107 on The Chemo-drug Sensitivity of Breast Cancer Cells.
Luo Y; Hua T; You X; Lou J; Yang X; Tang N
Open Med (Wars); 2019; 14():59-65. PubMed ID: 31346547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
